Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

MAR-FEBUXOSTAT DIN 02473607

Status: Marketed
Holder: MARCAN PHARMACEUTICALS INC
Molecule: FEBUXOSTAT (FEBUXOSTAT HEMIHYDRATE)
Available to quote

Health Canada record

Active ingredient(s)FEBUXOSTAT (FEBUXOSTAT HEMIHYDRATE) 80 MG
Dosage formTablet
RouteOral
SchedulePRESCRIPTION
ClassHuman
ATCM04AA03 FEBUXOSTAT
Original market date16-May-2019
Current status date16-May-2019
SourceHealth Canada DPD

Establishment licence of the holder

Marcan Pharmaceuticals Inc. — licence 101909, currently licensed, last inspection rating C (2024-05-21).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing FEBUXOSTAT (FEBUXOSTAT HEMIHYDRATE)

DINProductCompanyFormStrengthStatus
02533243AURO-FEBUXOSTATAURO PHARMA INCTabletFEBUXOSTAT (FEBUXOSTAT HEMIHYDRATE) 80 MGMarketed
02539837FEBUXOSTATSANIS HEALTH INCTabletFEBUXOSTAT (FEBUXOSTAT HEMIHYDRATE) 80 MGMarketed
02549425M-FEBUXOSTATMANTRA PHARMA INCTabletFEBUXOSTAT (FEBUXOSTAT HEMIHYDRATE) 80 MGMarketed
02466198TEVA-FEBUXOSTATTEVA CANADA LIMITEDTabletFEBUXOSTAT (FEBUXOSTAT HEMIHYDRATE) 80 MGMarketed

Notices of Compliance

NOCDateSubmissionReason
220842019-04-23Abbreviated New Drug Submission (ANDS)
Request a quote for MAR-FEBUXOSTAT

How to read a Canadian DIN record